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he decision for a cell to self-replicate requires passage
from G1 to S phase of the cell cycle and initiation of
another round of DNA replication. This commitment
is a critical one that is tightly regulated by many parallel
pathways. Signiﬁcantly, these pathways converge to result
in activation of the cyclin-dependent kinase, cdk2. It is,
therefore, important to understand all the mechanisms
regulating cdk2 to determine the molecular basis of cell
progression. Here we report the identiﬁcation and char-
acterization of a novel cell cycle gene, designated Speedy
(Spy1). Spy1 is 40% homologous to the 
 
Xenopus
 
 cell cycle
gene, X-Spy1. Similar to its 
 
Xenopus
 
 counterpart, human
Speedy is able to induce oocyte maturation, suggesting
similar biological characteristics. Spy1 mRNA is expressed
in several human tissues and immortalized cell lines and is
T
 
only expressed during the G1/S phase of the cell cycle.
Overexpression of Spy1 protein demonstrates that Spy1 is
nuclear and results in enhanced cell proliferation. In addition,
ﬂow cytometry proﬁles of these cells demonstrate a reduction
in G1 population. Changes in cell cycle regulation can be
attributed to the ability of Spy1 to bind to and prematurely
activate cdk2 independent of cyclin binding. We demonstrate
that Spy1-enhanced cell proliferation is dependent on cdk2
activation. Furthermore, abrogation of Spy1 expression,
through the use of siRNA, demonstrates that Spy1 is an
essential component of cell proliferation pathways. Hence,
human Speedy is a novel cell cycle protein capable of
promoting cell proliferation through the premature activation
of cdk2 at the G1/S phase transition.
 
Introduction
 
Movement through the cell cycle is dependent on the ac-
tivation and inactivation of catalytic proteins known as
 
cyclin-dependent kinases (cdks).* To promote cell cycle
progression, cdks must form an active complex with their
regulatory cyclin partners (for reviews see Ohi and Gould,
1999; Yang and Kornbluth, 1999). Commitment of the
cell to replicate the genome occurs during a highly regulated
stage in late G1, known as the restriction point. Consider-
able effort has been spent attempting to understand the
molecular mechanism by which a cell passes through this
restriction point. Although most research focuses on the
role of the cyclin D–cdk4/6–pRB–E2F cascade in mediating
this switch, evidence shows that the retinoblastoma (RB)
pathway alone cannot account for the G1/S control over this
transition point (Santoni-Rugiu et al., 2000). Evidence is ac-
cumulating to implicate that a parallel pathway, operating
through the proto-oncogene Myc, cooperates with the pRB–
E2F pathway to control G1/S onset (Roussel et al., 1995;
Leone et al., 1997; Beier et al., 2000). Importantly, all known
pathways that play a role in moving cells through the restriction
point converge on the control of the G1/S kinase, cdk2.
Because cdk2 is central in controlling cell proliferation, it
is subject to many levels of regulation. Although cdk2 is ex-
pressed relatively ubiquitously throughout the cell cycle, it is
highly regulated by a series of activating and inactivating
phosphorylations (Ekholm and Reed, 2000). Additionally,
cdk2 activity is limited by the availability of a cyclin binding
partner. Cyclin proteins are regulated at the protein expres-
sion level, being synthesized and destroyed in an oscillating
manner throughout the cell cycle, thereby assuring a narrow
window of cdk activation (Ekholm and Reed, 2000). In
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brary and contained 63% homology over a 170-bp region of
X-Spy1. Primers corresponding to this human EST clone
were designed and the corresponding full-length gene was
isolated from a human testis cDNA library. A PCR-based se-
rial dilution cloning method was used as described in the
Materials and methods. PCR and dilution plating were re-
peated until a single clone was isolated. Sequencing of this
1,300-bp cDNA clone revealed an open reading frame en-
coding a predicted polypeptide of 286 residues (Fig. 1 A).
This human clone shared an overall homology of 
 
 
 
40%
with X-Spy1, including one stretch of 150 amino acids (aa)
that shared 
 
 
 
70% homology (Fig. 1 B).
To confirm that the identified clone was the human ho-
Figure 1. Identification of human Spy1. (A) Nucleotide sequence 
and predicted aa sequence of human Spy1. (B) The alignment of the 
amino acid sequence of Xenopus Speedy (X-Spy1) is shown in 
comparison with the human homologue (H-Spy1) and p33
ringo 
(X-Ringo). A potential nuclear export signal sequence and a conserved 
acidic domain are shaded. The GenBank/EMBL/DDBJ accession no. 
for human Spy1 is pending.
 
mammalian cells, cdk2 forms active complexes with both cy-
clin E and cyclin A (Fang and Newport, 1991; for review see
Ekholm and Reed, 2000). Crystallography studies demon-
strate that cyclin binding allows for structural modifications
within the catalytic cleft of the cdk molecule, enhancing cdk
access to ATP and relative substrates (Jeffrey et al., 1995).
Furthermore, both the formation and the activity of the
cdk–cyclin complex are subject to inhibition by small inhib-
itory proteins (cdk inhibitors [CKIs]; Pines, 1994). Al-
though much is known about the regulatory mechanisms
governing cdk activation, questions still remain regarding
the precise timing and manner by which all of these regula-
tory mechanisms function, particularly during times of cel-
lular stress, DNA damage, and oncogenesis.
Previously, our laboratory reported the identification of a
novel 
 
Xenopus
 
 cell cycle regulatory gene, X-Spy1 (Lenor-
mand et al., 1999). Shortly after our publication of X-Spy1,
Ferby et al. (1999) reported the identification of a 
 
Xenopus
 
gene, p33
 
ringo
 
, which is 
 
 
 
90% homologous to X-Spy1. Mi-
croinjection of either X-Spy1 or p33
 
ringo
 
 mRNA into 
 
Xeno-
pus
 
 oocytes elicits rapid maturation in the absence of
hormone. Additionally, X-Spy1 and p33
 
ringo
 
 are essential
for progesterone-stimulated maturation of 
 
Xenopus
 
 oocytes
(Ferby et al., 1999; Lenormand et al., 1999). Moreover,
X-Spy1 and p33
 
ringo
 
 appear to be functionally redundant in
the maturation process, as inhibiting only one of these pro-
teins at a time with antisense oligonucleotides does not pre-
vent maturation (Ferby et al., 1999). Interestingly, in 
 
Xeno-
pus
 
 oocytes, X-Spy1 and p33
 
ringo
 
 were both found to bind
and prematurely activate cdk2 in a p21-independent manner
(Ferby et al., 1999; Lenormand et al., 1999). Recently, it has
been reported that activation of cdk2 by p33
 
ringo
 
 does not rely
on the phosphorylation of Thr161, suggesting a novel mech-
anism for cdk2 activation (Karaiskou et al., 2001). Thus,
X-Spy1 and p33
 
ringo
 
 represent a new class of cell cycle regula-
tory proteins that directly interact with and activate cdk2, in-
dependent of classical regulatory mechanisms.
Here we report the identification and characterization of
the human homologue of Speedy (Spy1). Similar to its 
 
Xeno-
pus
 
 counterpart, human Speedy is able to induce maturation
in 
 
Xenopus
 
 oocytes upon microinjection, suggesting a role in
cell cycle progression. Human Speedy mRNA is present in a
range of normal tissues and immortalized cell lines and is reg-
ulated in a cell cycle–dependent manner. We demonstrate
that Spy1 interacts with human cdk2 independent of cyclin
binding and stimulates its kinase activity in mammalian cells.
Furthermore, Spy1 overexpression in various cell lines rapidly
induces cell cycle progression, an action that is dependent on
cdk2 activation. Importantly, we show that depleting endoge-
nous Spy1 significantly decreases cell proliferation, demon-
strating a physiological function for Spy1. Thus, human
Speedy is a novel, essential inducer of cell cycle progression
that functions through a unique pathway of cdk2 activation.
 
Results
 
Identification of human Speedy (Spy1)
 
A database search for proteins homologous to 
 
Xenopus
 
Speedy yielded a partial match from an EST database. The
corresponding human EST clone was from a testis cDNA li- 
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mologue of Speedy, 
 
Xenopus
 
 oocytes were microinjected
with mRNA encoding for either X-Spy1 or human Spy1.
Oocytes were also treated with progesterone as a positive
control or injected with water as a negative control. Oo-
cytes were subsequently scored for germinal vesicle break-
down (GVBD) as indicated by the appearance of a white
spot on the animal pole. As shown in Fig. 2 A, Spy1 in-
duced oocyte maturation in the absence of hormone, al-
though not as efficiently as X-Spy1 or progesterone. A sub-
set of oocytes were fixed in 5% TCA and manually
dissected to confirm GVBD (unpublished data). Spy1-
induced maturation was notably slower than X-Spy1–
or progesterone-induced maturation (unpublished data).
Thus, we report the identification of human Spy1, a func-
tional homologue of X-Spy1.
A series of X-Spy1 deletion mutants were assayed to as-
certain which region is essential for activity. X-Spy1 was
used for this analysis because X-Spy1 functions optimally in
the 
 
Xenopus
 
 oocyte system. Six X-Spy1 deletion mutants
were constructed by sequentially removing 
 
 
 
50 aa at a
time. These mutants are designated 
 
 
 
1–
 
 
 
6 and were ana-
lyzed for their ability to induce GVBD in 
 
Xenopus
 
 oocytes
upon microinjection. Only two of these mutants retained
the ability to induce oocyte maturation, 
 
 
 
1 (corresponds to
a deletion of aa 5–53) and 
 
 
 
6 (lacks aa 218–268) (Fig. 2
B). These data imply that aa 54–218 are essential for the ac-
tivity of X-Spy1, whereas the NH
 
2
 
 and COOH termini are
dispensable. Thus, the center region of the protein, which is
also the most highly conserved between X-Spy1, p33
 
ringo
 
,
and Spy1 (Fig. 1 B), is required for X-Spy1 activity.
 
Speedy mRNA is expressed in a variety of human 
tissues and cell lines
 
To determine if Speedy mRNA is endogenously expressed in
a variety of normal human tissues and immortalized cell
lines, reverse transcriptase PCR (RT-PCR) was performed
on mRNA isolated from 15 different human tissues as well
as 3 different cell lines. Primers were used that are specific
for the conserved region of human Speedy. As shown in Fig.
3 A, Spy1 mRNA is expressed at high levels in human fetal
brain (lane 6) and the thyroid gland (lane 12). Significant
amounts of Spy1 mRNA are also detected in human thymus
(lane 3), salivary gland (lane 4), liver (lane 5), cerebellum
(lane 13), heart (lane 14), and placenta (lane 15). As shown
in Fig. 3 C, Spy1 mRNA is present in the human teratocar-
cinoma cell line Ntera-2 and the human embryonic kidney
293T cell line (lanes 3 and 4, respectively); yet Spy1 mRNA
was not detected in the human epitheloid carcinoma cell
line HeLa (lane 6). Notably, when mRNA levels for HeLa
cells are increased 10-fold, Spy1 RNA can be detected (un-
published data). As a control, Fig. 3, B and D, demonstrates
Figure 2. Human Spy1 induces GVBD in Xenopus oocytes. (A) 
Oocytes were injected with the indicated mRNA, incubated with 
progesterone (Prog) as a positive control, or injected with H2O as a 
negative control, and scored for GVBD by the formation of a white spot 
on the animal pole. This graph is the composite of three independent 
experiments. (B) Deletion mutants of Xenopus Spy1 define a minimal 
activation domain of X-Spy1. Oocytes were injected with the indicated 
mRNA or incubated with progesterone and scored for GVBD. Deletion 
mutants are missing the following aa:  1 (5–53),  2 (54–94),  3 
(98–137),  4 (137–170),  5 (173–218), and  6 (218–268).
Figure 3. Human Spy1 mRNA is present in a variety of human tissues 
and immortalized cell lines. (A) RT-PCR of mRNA from 15 different 
human tissues. Lane 1 is a negative RT-PCR control containing no 
mRNA. Lane 2 is a positive RT-PCR control using control RNA with 
control primers. Human tissue samples are as follows: lane 3, 
thymus; 4, salivary gland; 5, liver; 6, fetal brain; 7, adrenal gland; 
8, bone marrow; 9, fetal liver; 10, lung; 11, skeletal muscle; 12, 
thyroid; 13, brain/cerebellum; 14, heart; 15, placenta; 16, spleen; 
17, trachea. (B) Control formaldehyde gel demonstrating the quality 
and quantity of the mRNA used in A. (C) RT-PCR of mRNA prepared 
from Ntera-2 cells (lane 3), 293T cells (lane 4), Spy1-transfected 
293T cells (lane 5), and HeLa cells (lane 6). Lanes 1 and 2 are 
RT-PCR controls with a control mRNA and no mRNA, respectively. 
(D) Control formaldehyde gel demonstrating the quality and quantity 
of the mRNA used in C. Lanes 1–4 correspond to lanes 3–6 in C. 
(E) RT-PCR of mRNA prepared from synchronized 293T cells at 
various stages of the cell cycle. Lanes 1 and 2 are RT-PCR controls 
with no mRNA and control mRNA, respectively. (F) Control formal-
dehyde gel demonstrating the quantity and quality of the mRNA 
used in E. Lanes 1–5 correspond to lanes 3–7 in E. 
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that the total mRNA used was of equal quality and quantity.
PCR products were sequenced to confirm that the 360-bp
band was indeed Speedy (unpublished data). Smaller bands
did not have informative sequences and are likely degrada-
tion products of Spy1. Thus, Spy1 mRNA is expressed in
both a variety of immortalized cell lines as well as in several
human tissue types.
 
Speedy mRNA is expressed in 
a cell cycle–dependent manner
 
To determine if Spy1 mRNA expression is cell cycle depen-
dent, 293T cells were synchronized via double thymidine
block and mRNA was prepared hourly after release of the
cells. The cell cycle phase distribution was previously deter-
mined using flow cytometry analysis (unpublished data). At
each time point, immunofluorescence was used to confirm
morphological changes. Mitotic events occurred at 
 
 
 
8 h af-
ter release, which was consistent with earlier studies. The
mRNA samples that correspond to each phase of the cell cy-
cle (lane 3, G0; lane 4, G1; lane 5, G1/S; lane 6, G2; lane 7,
G2/M) were subjected to RT-PCR using primers specific for
human Speedy. As demonstrated in Fig. 3 E, Spy1 mRNA
was only expressed in G1/S phase cells (lane 5). The quan-
tity and quality of the total mRNA used in RT-PCR analysis
is shown in Fig. 3 F.
 
Spy1 is localized in the nucleus and interacts 
with human cdk2
 
To determine the subcellular localization of Speedy, a myc-
tagged human Speedy construct (myc–Spy1) was engi-
neered. COS-1 cells were transiently transfected with
myc–Spy1 or an empty vector as a control. Indirect immu-
nofluorescence was then performed to examine the subcellu-
lar localization of Spy1. Treatment of cells with the c-myc
(9E10) antibody showed that myc–Spy1 was expressed ex-
clusively in the nucleus (Fig. 4 A, bottom left). Hoechst dye
was used to stain the nuclei of all cells (Fig. 4 A, right).
Previously, our lab demonstrated that X-Spy1 was able to
directly bind to cdk2 (Lenormand et al., 1999). As cdk2 and
Figure 4. Human Spy1 binds to and activates cdk2. (A) Indirect 
immunofluorescence on COS-1 cells transiently transfected with 
human myc-tagged Spy1 (myc–Spy1; bottom left) or with empty 
vector (mock; top left) shows myc–Spy1 in the nucleus. The 
corresponding panels on the right are stained with Hoechst dye to 
illuminate the nuclei of all the cells present. (B) Coimmunoprecipi-
tation of transiently transfected myc–Spy1 with endogenous cdk2 
from 293T cells. Western blot analysis using antibodies against the 
myc epitope tag (top) or against cdk2 (bottom). Lane 1 is lysate from 
mock-transfected cells. Lane 2 is lysate from myc–Spy1-transfected 
cells. Lanes 3 and 4 are immunoprecipitations (IPs) from mock-
transfected cells, and lanes 5 and 6 are immunoprecipitations from 
myc–Spy1-transfected cells using either anti-cdk2 (lanes 3 and 5) or 
anti-myc (lanes 4 and 6). (C) Top panel shows histone H1 phosphory-
lation assay. 293T cells were transiently transfected with empty 
vector (mock) or myc–Spy1. 24 h after transfection, cells were 
harvested and immunoprecipitated with antibodies against cdk2. 
Lane 1 is histone H1 alone (no IP). Lanes 2 (mock) and 3 (myc–Spy1) 
are cdk2 IPs. Bottom panel shows blot of cdk2 in IPs from mock and 
myc–Spy1 cells. (D) Top panel shows histone H1 phosphorylation 
assay. 293T cells were transiently transfected with empty vector 
(mock) (lane 1) or myc–Spy1 (lane 2). 24 h after transfection, cells 
were harvested and immunoprecipitated with antibodies against 
cdc2. Coomassie blue staining showing equal loading of cdc2 is 
presented in the bottom panel.
Figure 5. Expression of Spy1 increases the rate of proliferation 
of mammalian cells. Growth curves of (A) HeLa cells, (B) NIH3T3 
cells, and (C) Ntera-2 cells. All cells were transiently transfected 
with myc–Spy1 ( ) or empty vector ( ). Cells were collected in 
triplicate at the indicated time point and counted via trypan blue 
exclusion. The graph is one representative experiment of at least three 
independent experiments. Error bars were calculated using SEM. 
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Spy1 are both nuclear, we investigated whether human Spy1
could directly interact with human cdk2. To accomplish
this, 293T cells were transiently transfected with myc–Spy1
or an empty vector control. Cell lysates were subsequently
coimmunoprecipitated with either cdk2 or c-myc antibodies.
Immunoblot analysis showed that myc–Spy1 coimmuno-
precipitates with endogenous cdk2 (Fig. 4 B). Specifically,
immunoblotting for myc–Spy1 revealed that myc–Spy1 was
present in a cdk2 immunoprecipitation from myc–Spy1-
transfected cells (Fig. 4 B, lane 5), but not from mock-trans-
fected cells (Fig. 4 B, lane 3). Similar results were obtained
in the reverse direction. Immunoblotting for cdk2 showed
that cdk2 was present in a myc–Spy1 coimmunoprecipita-
tion in myc–Spy1-transfected cells (Fig. 4 B, lane 6), but not
in mock-transfected cells (Fig. 4 B, lane 4). These results in-
dicate that human Spy1, analogous to its 
 
Xenopus
 
 homo-
logue, binds cdk2 in vivo.
We then wished to examine the kinase activity of cdk2.
Lysates from mock- or myc–Spy1-transfected 293T cells
were immunoprecipitated with antibodies against cdk2 and
subjected to an in vitro histone H1 phosphorylation assay.
Speedy-expressing cells had a significant increase in cdk2 ki-
nase activity (Fig. 4 C, top). As a control, the protein levels
of cdk2 were examined and found to be present in equiva-
lent levels (Fig. 4 C, bottom). Although H1-associated ki-
nase activity is widely used and highly indicative of the rela-
 
tive levels of kinase activity, the actual alteration in cdk2
activity on in vivo substrates may differ. These results indi-
cate, consistent with prior observations in 
 
Xenopus
 
 oocytes,
that human Spy1 binds to cdk2 and stimulates cdk2 kinase
activity.
Interestingly, we have been unable to show consistent
binding of Spy1 with any of the cyclins (unpublished
data). Furthermore, when lysates from mock- or myc–Spy1-
transfected cells were immunoprecipitated with antibodies
against cdc2 and subjected to an in vitro histone H1 phos-
phorylation assay, we found no significant increase in cdc2
kinase activity in Spy1-expressing cells (Fig. 4 D, top) that
have equal levels of cdc2 protein (Fig. 4 D, bottom).
 
Spy1 enhances cell proliferation in mammalian cells
 
To determine if Spy1 plays a role in regulating the mamma-
lian cell cycle, growth curves were obtained comparing
control-transfected cells against cells expressing myc–Spy1.
Transiently transfected HeLa, NIH3T3, and Ntera-2 cells
were counted every 24 h after transfection for 96 h. As
shown in Fig. 5, A–C, cells overexpressing Spy1 grew signif-
icantly faster than mock cells. Trypan blue exclusion was
used to distinguish between live and dead cells and no ap-
preciable difference was noted in cell death (unpublished
data). These data indicate that Spy1 expression enhances
overall cell growth rate.
To determine which aspects of cell growth are affected by
Speedy expression, several markers were examined in 293T
cells transiently transfected with myc–Spy1 or an empty vec-
tor control. Fig. 6 A demonstrates that, like the other cell
lines studied, 293T cells expressing myc–Spy1 proliferate at
a considerably faster rate than cells with an empty vector
Figure 6. Expression of Spy1 increases both the rate of cell 
replication and division. (A) Growth curve of 293T cells transiently 
transfected with myc–Spy1 ( ) or empty vector ( ). Cells were 
collected at the indicated times, counted on a Coulter counter, and 
replated. The graph is the average of three independent experiments. 
Error bars were calculated using SEM. (B) Increase of BrdU 
incorporation in myc–Spy1-transfected 293T cells. Cells were 
harvested at day 2, stained for BrdU, and the positive cells were 
counted via fluorescence microscopy. Error bars represent the standard 
error of three experiments. (C) MTT analysis of 293T cells expressing 
myc–Spy1 ( ) or empty vector ( ). Cells were collected at the 
indicated times, treated, and then the absorbance was taken at 570 
nm to determine the relative levels of MTT. Bars represent the standard 
error between four separate transfections within one representative 
experiment. (D) Histone H3 phosphorylation in myc–Spy1-transfected 
293T cells. Cells were harvested at day 2, stained for phosphorylated 
histone H3, and the positive cells were counted via fluorescence 
microscopy. Bars represent the standard error of three separate 
experiments.
Figure 7. Spy1-enhanced growth is dependent on cdk2 activation. 
(A) Growth curve of 293T cells transiently transfected with Spy1 
( ); mock ( ); Spy1   dncdk2 (cdk2D145N) ( ); mock   dncdk2 
(X); Spy1   7  M olomoucine ( ); mock   7  M olomoucine ( ). 
Error bars represent the SEM between triplicate plates of one repre-
sentative experiment. This experiment was repeated three times. (B) 
Western blot of lysates from each sample at 96 h. The blot was then 
probed for myc–Spy1 expression. 
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control. To determine the percentage of cells synthesizing
DNA at a given time, the incorporation of BrdU, a thy-
midine analogue, into DNA was studied in cell popula-
tions transfected with either mock or Spy1 (Wang et al.,
1996). Using immunofluorescence microscopy, Spy1-express-
ing cells showed a threefold increase in BrdU incorporation
(Fig. 6 B). Thus, cells expressing Speedy have an increase in
DNA replication events, which is consistent with cells cy-
cling more rapidly. Furthermore, a 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay was
performed on 293T cells transiently transfected with myc–
Spy1 or empty vector to examine mitochondrial activity.
This assay measures the activity of the mitochondrial enzyme
succinic dehydrogenase (Twentyman and Luscombe, 1987).
A significant increase in mitochondrial activity was seen in
cells expressing Spy1 (Fig. 6 C). These data indicate that
Speedy-expressing cells are undergoing cellular replication at
a higher or more efficient rate than mock cells, consistent
with the observation that Spy1 enhances cell proliferation.
To identify if Spy1-transfected cells were also successfully
dividing more frequently than mock-transfected cells, we
used a phospho-specific antibody to detect a form of histone
H3 present only in mitotic nuclei (anti-PH3; Handzel et al.,
1997). Using immunofluorescence, Spy1-expressing cells
displayed a twofold increase in the phosphorylation of his-
tone H3 (Fig. 6 D). This indicates that the presence of Spy1
induces cells to divide more rapidly. Taken together, Spy1-
expressing cells replicate and divide at a faster rate than
mock-transfected cells; therefore Spy1 functions in enhanc-
ing cell proliferation.
 
Spy1-enhanced cell proliferation is dependent on cdk2 
kinase activity
 
To determine if Spy1 requires cdk2 kinase activity in order
to enhance cell proliferation, we used a dominant-negative
cdk2, cdk2D145N (van den Heuvel and Harlow, 1993).
We additionally exploited a drug known to selectively in-
hibit cdk2 at low doses, olomoucine (Vesely et al., 1994).
The dose of olomoucine used, 7 
 
 
 
M, is the IC50 value for
cdk2 and cdc2 inhibition. This dose has no effect on any
other kinase tested including both cdk4 and cdk6 (Vesely et
al., 1994). Fig. 7 A demonstrates that Spy1 is unable to
stimulate proliferation of cells where cdk2 kinase activity has
been inhibited either through the use of the dominant-nega-
tive cdk2 or olomoucine. This is not due to an alteration in
the expression of myc–Spy1 protein (Fig. 7 B).
 
Spy1 reduces the percentage of cells in G1 phase 
of the cell cycle
 
Flow cytometry was then employed to determine if Spy1 se-
lectively alters one or more phases of the cell cycle. Fig. 8 A
shows a representative flow cytometry profile of 293T cells
transiently transfected with mock or Spy1. Notably, overex-
pression of Spy1 was not toxic to cells and did not initiate a
cell cycle arrest. The graph shown in Fig. 8 B demonstrates
that Spy1-expressing cells consistently exhibit a lower per-
centage of cells in G1 phase of the cell cycle. As G1 phase is
the longest phase of the cell cycle, this may provide one ex-
planation for Spy1-enhanced rate of cell proliferation. Of
course, these results do not rule out the possibility that
Spy1-expressing cells may also exhibit alterations in the tim-
ing of other phases of the cell cycle.
 
Spy1 expression is necessary for normal cell growth
 
To determine the physiological role of Spy1 in enhancing
cell growth, small interference RNA (siRNA) techniques
were employed. Transient transfection of 293T cells with
siRNA constructs designed against Spy1 (siSpy) depletes the
cells of Spy1 mRNA by 24 h (Fig. 9 B). Depletion of Spy1
mRNA persists over the time course of the experiment, from
24 through 96 h after transfection. Using a control siRNA
directed against luc-GL2 (siCntl), a bacterial reporter, no ef-
fect was observed on Spy1 mRNA or overall RNA levels
(Figs. 9, B and C). As demonstrated in Fig. 9 A, depleting
Spy1 mRNA in 293T cells has a drastic effect on cell growth
as indicated by trypan blue exclusion, which is especially ev-
ident by 96 h after transfection. Fig. 10 A demonstrates that
the mitotic index of cells depleted of endogenous Spy1 for
72 h is significantly lower than that of siCntl cells, support-
ing that endogenous Spy1 is involved in promoting en-
hanced cell division. FACS
 
®
 
 analysis of this same population
of cells demonstrates that siSpy1-transfected cells have a
higher percentage of cells in late G1/early S phase (68%) as
compared with siCntl-transfected cells (54%) (Fig. 10 B).
This alteration in cell cycle distribution has consistently
been observed over a wide range of time points (unpublished
data). Furthermore, under these experimental conditions,
cdk2-associated H1 kinase activity in cells depleted of en-
dogenous Spy1 decreases to 
 
 
 
35% of the siCntl-transfected
cells (Fig. 10 C). Fig. 10 D demonstrates through Western
Figure 8. Speedy increases cell division and decreases the G1 
population. 293T cells were transiently transfected with empty 
vector or myc–Spy1. Cells were collected 24, 30, 36, and 48 h after 
transfection and analyzed by flow cytometry. (A) A representative 
FACS
® profile of cells overexpressing empty vector (mock) or 
myc–Spy1. (B) Graphic representation of the percentage of cells in 
G1 phase. Mock, black bars; myc–Spy1, gray bars. Error bars represent 
the SEM of four independent experiments. 
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blot analysis that endogenous Spy1 protein is successfully
depleted after transfection with Spy1 siRNA. Hence, these
data demonstrate that depletion of Spy1 mRNA hinders cell
proliferation, implicating endogenous Spy1 as an essential
protein in normal cell growth.
 
Discussion
 
In this report, we characterize the novel human cell cycle
gene, Spy1. Akin to its homologous 
 
Xenopus
 
 relative, Spy1
induces maturation of 
 
Xenopus
 
 oocytes upon microinjection.
In mammalian cells, we demonstrate that Spy1 is a regulator
of cell cycle progression. Overexpression of Spy1 increases
proliferation in several mammalian cell lines, as indicated by
cell growth curves. This may be explained by the ability of
Spy1 to bind to and prematurely activate the G1/S kinase,
cdk2. In support of this, flow cytometry studies using 293T
cells demonstrate that Spy1 decreases the overall population
of cells in G1 phase of the cell cycle. Furthermore, cells over-
expressing Spy1 demonstrate an enhancement in the incor-
poration of BrdU and in MTT activity, respectively, indicat-
ing that both DNA synthesis and mitochondrial enzyme
activity are enhanced. Taken together, Spy1 appears to be a
potent regulator of cell cycle progression.
Previous studies demonstrated that the 
 
Xenopus
 
 Spy1 ho-
mologues, X-Spy1 and p33
 
ringo
 
, bind to and activate cdk2
(Ferby et al., 1999; Lenormand et al., 1999). Moreover,
p33
 
ringo
 
 was shown to bind to and activate cdc2 (Ferby et al.,
1999). In these studies, X-Spy1 and p33
 
ringo
 
 are associated
with rapid oocyte maturation, demonstrating the ability of
X-Spy1 to progress cells through the G2/M transition of the
cell cycle. Similar to these reports, we have found that hu-
man Speedy activates cdk2 in mammalian cells. Yet contrary
to the 
 
Xenopus
 
 system, Spy1 in mammalian cells is associated
with rapid progression of cells through G1/S. Furthermore,
under our experimental conditions, we have been unable to
demonstrate any direct binding of Spy1 with cdc2 or any
enhanced activity of cdc2 in Spy1-expressing cells. We do,
however, demonstrate that Spy1-expressing cells exhibit en-
hanced expression of phospho-histone H3, an indicator of
cell division, and thus cannot rule out that Spy1 may exert
some as yet undetermined effects in G2/M phase of the cell
cycle. The apparent discrepancies between results obtained
with 
 
Xenopus
 
 p33
 
ringo
 
 (Ferby et al., 1999; Karaiskou et al.,
2001) and human Spy1 may possibly be explained by spe-
cies differences in the regulatory properties of the Spy1 pro-
tein itself. It is evident from this report that Spy1 mRNA is
Figure 10. Depletion of Spy1 protein decreases cdk2-associated 
kinase activity and slows movement of cells into M phase of the 
cell cycle. (A) Mitotic index of cells expressing siSpy or siluc-GL2 
(siCntl) 72 h after transfection. Error bars represent the average of 
three separate transfections. This is one representative experiment of 
three. (B) FACS
® analysis of siSpy- and siCntl-expressing cells 72 h 
after transfection. Data were analyzed by M-cycle. One representative 
experiment of three is shown. (C) Cdk2-associated histone kinase 
activity was measured for cells transfected for 72 h with siSpy and 
siCntl. Data were quantitated using NIH Image 1.62. Similar 
alterations in kinase activity are observed over a range of time 
points. (D) Western blot control demonstrating that endogenous 
Spy1 protein is depleted 72 h after transfection of siSpy siRNA.
Figure 9. Endogenous Spy1 is required for normal cell growth. 
Spy1 RNA was depleted using RNA interference. (A) 293T cells were 
transiently transfected with siRNA directed against Spy1 (siSpy) ( ) or 
siluc-GL2 control (siCntl) oligonucleotides ( ). 24 h after transfection, 
triplicate plates were counted by trypan blue exclusion. The surviving 
cell number was graphed as an average of three plates ( SEM). (B) 
mRNA was isolated from remaining cells from each time point and 
was subjected to RT-PCR analysis. Lanes indicated with a plus have 
been treated with siSpy, and lanes indicated with a minus have been 
treated with siCntl. (C) Control 1.2% agarose formaldehyde gel 
demonstrating the quantity and quality of the mRNA used in B. 
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detectable primarily during G1/S phase of the cell cycle in
mammalian cells. Additionally, our laboratory has prelimi-
nary data suggesting that Spy1 protein is degraded during
G2 phase of the cell cycle (unpublished data). 
 
Xenopus stud-
ies, on the other hand, indicate that X-Spy1 and p33
ringo pro-
tein exists at the G2/M border (Ferby et al., 1999; Lenor-
mand et al., 1999). The fact that Spy1 is differently regulated
between species is interesting and merits further investigation.
The possibility that Spy1 has biological function at vari-
ous phases of the cell cycle depending on its production and
destruction is itself interesting and reflects a characteristic
common to the growing family of cyclin proteins. Further-
more, we demonstrate here that Spy1 mRNA is expressed in
a cell cycle–dependent manner, similar to cyclin expression
profiles. Yet, at the amino acid level, Spy1 is not signifi-
cantly related to the archetypical cyclins. Future experiments
determining the mechanism by which Spy1 activates cdk2
will reveal if Spy1 is indeed a potential cyclin-like protein.
We cannot yet rule out that Spy1 is binding cdk2 via a com-
plex containing other proteins. Perhaps Spy1 functions by
altering the binding of cell cycle inhibitors to cdks.
Recently p33
ringo was demonstrated to activate both cdc2
and cdk2 regardless of the phosphorylation status of Thr160
and Thr161, respectively, and in the absence of cyclin bind-
ing (Karaiskou et al., 2001). This implies that X-Spy1 and
p33
ringo activate their relevant cdk via a unique mechanism.
Interestingly, we have been unable to observe any cyclin
binding to Spy1 via coimmunoprecipitation (unpublished
data). This suggests that Spy1, like p33
ringo, activates cdk2
via a unique pathway that is independent of cyclin binding.
Consistent with this, depletion of Spy1 mRNA slows cell
growth considerably, yet cells are still able to replicate and
divide. Additionally, Spy1 mRNA is found at vastly differ-
ent levels in select tissues, suggesting that Spy1-mediated
cdk2 activation will have unique tissue-specific functions. It
will be interesting to further determine how Spy1 binds and
activates cdk2 and to determine the effects of Spy1 on cdk2–
cyclin E/cyclin A complex formation. It is becoming increas-
ingly evident that there are multiple pathways leading to
cdk2 activation, ultimately promoting entry into S phase.
The most well-established pathway leading to S phase is the
RB pathway, comprising RB protein along with its upstream
regulators cyclin D and cdk4/6 and pRB-regulated E2F
transcription factors (Bartek et al., 1996). Accumulating evi-
dence supports that the proto-oncogene Myc functions in
parallel to RB in a pathway that is independent of E2F acti-
vation (Santoni-Rugiu et al., 2000). It will be interesting to
determine if Spy1 is a critical component of one of these
pathways regulating the onset of DNA replication. More-
over, it will be important to address if Spy1–cdk2 binding is al-
tered during times of cellular stress or DNA damage, because
Spy1 was initially isolated by its ability to rescue a Rad1-defi-
cient strain of Schizosaccharomyces pombe from UV damage.
In summary, the results presented here characterize a
novel human cell cycle gene that plays a role in the progres-
sion of mammalian cells through its ability to bind and acti-
vate cdk2. We have established that endogenous Spy1 is es-
sential for the proliferation of mammalian cell lines and that
Spy1 is expressed over a wide range of human tissues, open-
ing up the possibility that this gene may be involved in hu-
man cell cycle disorders such as oncogenesis. There are nu-
merous questions remaining regarding the regulation of
Spy1; the answers of which may provide valuable insight
into the mechanics of the mammalian cell cycle.
Materials and methods
Identification of human Speedy
A BLAST search of the EST database using X-Spy1 as the “bait” yielded one
clone of significant homology (GenBank/EMBL/DDBJ accession no.
AA424209). The EST clone was isolated from a human testis cDNA library.
Thus, using primers directed against highly conserved regions of X-Spy1
and AA424209, we screened a human testis cDNA library (CLONTECH
Laboratories Inc.) using a PCR-based dilution cloning method to isolate
human Spy1. First, the library was plated on 10 plates at 100,000 plaque
forming units/plate and allowed to grow for  7 h and was then overlaid
with SM buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 8 mM MgSO4,
0.01% gelatin). PCR of the overlaid SM buffer (1  l aliquot) was used to
test for the presence of the desired clone on individual plates. The SM
overlay containing a positive was then titered and plated out again on 10
plates at 10,000 pfu/plate. The PCR and titering were repeated with the
positive plate replated onto 10 plates at 1,000 pfu/plate. After further PCR
and titering, the positive plate at the 1,000 pfu/plate dilution was replated
onto one plate. This plate was cut into 96 pieces and each was then placed
in a 96-well plate followed by the addition of 100  l SM buffer. At this di-
lution, each well should contain  10–15 clones. Well no. C-12 tested
positive and was replated at several dilutions to obtain a single clone con-
taining the desired insert. Individual clones were picked and examined by
PCR. One isolated plaque tested positive and the insert was shuttled to
pSP64 and pcDNA3 vectors.
Plasmid construction and mRNA isolation
Human Speedy was isolated from a testis library in a  TriplEx vector
(CLONTECH Laboratories Inc.). pTriplEx was excised from  TriplEx per the
manufacturer’s instructions. EcoRI and SacI sites were used to move hu-
man Spy1 from pTriplEx to pSB5, a modified version of pSP64(polyA)
(Promega) containing EcoRI in the multicloning region with XhoI instead of
EcoRI as the linearization site. To generate the myc–Spy1 clone, a NdeI
site that incorporates the start codon of human Speedy was added via
QuikChange site-directed mutagenesis (Stratagene). A pair of oligonucle-
otides (D1904/D1905) was inserted into the multicloning region of the
pCS3   MT vector at the BglII site, inserting a NdeI site in which the ATG
was in frame with the myc tag coding region. Then Spy1 was ligated into
pCS3   MT via a three-part ligation using HindIII, NdeI, and XbaI sites to
construct myc–Spy1. The X-Spy1 gene in the pSP64 vector was con-
structed as described previously (Lenormand et al., 1999). The deletion
mutants of X-Spy1 were constructed by first inserting two silent restriction
sites into X-Spy1 via QuikChange site-directed mutagenesis (Stratagene). A
pair of oligonucleotides (D2423/D2424) inserted a NcoI silent site at aa 94
of X-Spy1 and a second pair of oligonucleotides (D2433/D2434) inserted
a XhoI silent site at aa 137 of X-Spy1 in pSP64(poly A). Subsequently,
X-Spy1 was cut with either NdeI/NcoI, NcoI/XhoI, or XhoI/BamHI, and in
each case an  100-aa piece of X-Spy1 was removed. Then  50 aa were
added back, via a pair of complementary oligonucleotides, in frame to cre-
ate the deletion mutants lacking  50 aa each. The pairs of oligonucle-
otides used were as follows: D2426/2427 for  1; D2428/D2429 for  2;
D2435/D2436 for  3; D2437/D2438 for  4; D2439/D2440 for  5; and
D2441/D2442 for  6. mRNAs were synthesized from pSP64 constructs us-
ing SP6 polymerase as described previously (Freeman et al., 1989).
The dominant-negative cdk2 vector (pCMV-cdk2D145N) was a gift
from Ed Harlow and Sander van den Heuvel (Massachusetts General Hos-
pital Cancer Center, Charlestown, MA), and has been previously described
(van den Heuvel and Harlow, 1993).
Oocyte microinjections
Stage VI oocytes were dissected manually in modified Barth saline–Hepes
(MBS-H) buffer. They were then either treated with progesterone (30  M), mi-
croinjected with 50 nl of RNA at 1.0 mg/ml, or microinjected with 50 nl of di-
ethylpyrocarbonate (DEPC)-treated H2O and scored for GVBD as indicated by
the appearance of a white spot on the animal pole, as described previously
(Freeman et al., 1989).
Cell culture and synchronization
293T cells are a human embryonic kidney cell line (American Type Culture
Collection [ATCC]), Ntera-2 cells are a human teratocarcinoma cell line Human Spy1 enhances cell proliferation | Porter et al. 365
(ATCC), HeLa cells are a human epitheloid carcinoma cell line (ATCC),
COS-1 cells are an SV40-transformed African green monkey kidney cell
line (ATCC), and NIH3T3 cells are an embryonic, contact inhibited, NIH
Swiss mouse cell line (ATCC). All of these cell lines were maintained in
DME (GIBCO BRL) supplemented with 0.1% penicillin–streptomycin
(Sigma-Aldrich) and 10% FBS. Ntera-2 cells were also supplemented with 4
mM  L-glutamine (Sigma-Aldrich). Cells were incubated at 37 C in 10%
(293T, COS-1, and Ntera-2 cells) or 5% CO2 (HeLa and NIH3T3 cells).
Double thymidine block was used to synchronize the cell cycle. 293T
cells were first treated with 100 mM thymidine in DME for 19 h at 37 C in
10% CO2. Cells were then washed with Tris-saline and incubated in fresh
media for 9 h. Thymidine/DME was then added for the second thymidine
block, and cells were incubated for 17 h. The final Tris-saline wash and in-
cubation in fresh media was followed by the beginning of time points, as
cells exit simultaneously from Go of the cell cycle.
Human Spy1 antibody isolation
The human Spy1 antibody was produced in collaboration with Pocono
Rabbit Farm and Laboratory. Rabbits were immunized with KLH-conju-
gated peptides against aa 251–263 of human Spy1. ELISAs were performed
using BSA-conjugated peptide, and further boosts were done every 2 wk
with the KLH-conjugated peptide. Specificity of the antibody was deter-
mined using peptide-blocked antibody and preimmune serum derived
from the same rabbit. The human Spy1 antibody specifically detects an en-
dogenous protein of  34 kD.
RT-PCR
Total RNA from 15 different human tissues was obtained from the Hu-
man Total RNA Master Panel II (CLONTECH Laboratories, Inc.). Total
RNA was prepared from cells (3   10
6) using RNeasy (QIAGEN) per the
manufacturer’s instructions. The quantity and quality of mRNA were
identified by running samples on a 1.2% agarose formaldehyde gel. 1  g
of RNA was reverse transcribed with 2.5 U of AMV reverse transcriptase
following the supplier’s suggestions (Promega). The reverse transcriptase
reactant was mixed in a final volume of 20  l together with 50 pmol of
primer pairs and 25  M of each deoxynucleoside triphosphate (dNTP)
and amplified with 2.5 U of Tf1 DNA polymerase (Promega) for 30 cy-
cles (denaturation at 94 C for 30 s, annealing at 55 C for 30 s, and exten-
sion at 68 C for 1 min). This number of cycles was previously determined
to be optimal for detecting the signal in a linear range. The primer se-
quences used were 5 -ATT GGG AAA CCA AAA TGA GGC-3  (sense)
and 5 -TCC TGG TAT GCT CAC TTA TAG-3  (antisense). Positive control
RNA and primers were included with the Access RT-PCR System
(Promega) and used per the manufacturer’s instructions. Amplification
products were visualized and photographed using TAE/EtBr gel electro-
phoresis. Products were then gel purified using GeneClean (Bio101), fol-
lowing the manufacturer’s instructions, and were cloned using the
pGEM-T Easy Vector System. Each of the cloned products was then se-
quenced (UCSD Cancer Center DNA Sequencing Service).
Immunofluorescence microscopy
293T or COS-1 cells were plated onto glass coverslips (collagen coated for
293T cells) and cultured as described above. Cells were transiently trans-
fected by calcium phosphate precipitation (Chen and Okayama, 1987) with
5  g of myc–Spy1 in a 60-mm dish. 36–48 h after transfection, cells were
fixed with 3% paraformaldehyde in PBS for 15 min and permeabilized with
0.1% Triton X-100 for 10 min. The 9E10 monoclonal myc antiserum (Santa
Cruz Biotechnology, Inc.) was used to detect myc–Spy1 with FITC-conju-
gated goat anti–mouse secondary antibody (Boehringer).
For M phase marker assay (phospho-histone H3), 293T cells were incu-
bated in blocking solution (0.1% Triton-X, 1.5% glycine, 2.5% FBS in PBS)
for 30 min at room temperature (RT). An antisera that specifically recog-
nizes the phosphorylated form of histone H3 (Upstate Biotechnology) was
added at a 1:200 dilution in blocking solution for 1 h at RT. FITC-conju-
gated anti–mouse was then used at a 1:200 dilution.
For S phase marker assay (BrdU), 293T cells were treated as described
above. In addition, 100  l of 6 mg/ml BrdU labeling solution in PBS was
added on the second day after transfection for 1 h at 37 C in 10% CO2.
Anti-BrdU (Becton Dickinson) was added to coverslips at a 1:50 dilution in
blocking solution for 1 h at RT. FITC-conjugated anti–mouse was used at a
dilution of 1:150 for visualization.
Immunoprecipitations and immunoblotting
Subconfluent 293T cells were transfected with 5  g of DNA by calcium
phosphate precipitation in a 10-cm dish. 24 h later, cells were harvested
and lysed in 0.1% NP-40 lysis buffer (20 mM Tris, pH 8.0, 150 mM NaCl,
0.1% NP-40, 1 mM Na3VO4, 1 mM NaF, 1 mM PMSF, 1 mM DTT, 10  g/
ml aprotinin, 10  g/ml pepstatin A, 10  g/ml leupeptin).
For immunoprecipitation, cell lysates were clarified with protein A–Seph-
arose beads (Sigma-Aldrich) and subsequently incubated with primary anti-
sera (myc–9E10, cdk2-D12, cdk2-M2, cdc2-p34 [17]; Santa Cruz Biotechnol-
ogy, Inc.) as indicated overnight at 4 C, followed by the addition of protein
A–Sepharose and incubation at 4 C with gentle rotation for an additional 1 h.
These complexes were then washed extensively with 0.1% NP-40 lysis buffer
and resolved by 10% SDS-PAGE. The membrane was immunoblotted with
the indicated antisera followed by ECL (Amersham Pharmacia Biotech). The
histone H1 kinase assays were performed as previously described (Kong et
al., 2000). siRNA-treated cells were serum starved using media containing
0.2% FBS for 12 h before harvesting for histone kinase assays.
Cell proliferation assays
Cell growth curves.  HeLa, NIH3T3, and Ntera-2 cells were seeded at a
density of 10
5 cells/plate (10 cm) and were transfected in triplicate 24 h
later with 5  g of either empty vector or myc–Spy1. Every 24 h after trans-
fection, three plates of both myc–Spy1 or empty vector control were
trypsinized and counted by trypan blue exclusion. The average values of
three plates are represented ( SEM). Coverslips were placed on each plate
to assess transfection efficiency by indirect immunofluorescence. HeLa
cells transfected with 40% efficiency, Ntera-2 cells with 45% efficiency,
and NIH3T3 cells with 30% efficiency. Remaining cells for that time point
were pooled, lysed, subjected to SDS-PAGE, and immunoblotted for myc–
Spy1 expression. This experiment was repeated three times.
293T cells were seeded at a density of 5   10
4 cells/plate (60 mm) and
were transfected 24 h later with 2.5  g of either empty vector or myc–
Spy1. 293T cells demonstrated a transfection efficiency of 50%, as as-
sessed by immunofluorescence. Cells were trypsinized and counted every
24 h after transfection (day 1). The average values of three plates are repre-
sented ( SEM). Cell lysate samples from day 4 were analyzed for myc–
Spy1 expression by immunoblotting.
Tetrazolium assay. 293T cells, transfected as described above, were split
onto a 96-well plate. 20  l of MTT (Sigma-Aldrich) stock (5 mg/ml in PBS)
was added to each and incubated at 37 C in 10% CO2 for 2 h. Then 100
 l of extraction buffer (20% SDS in DMF/H2O, 2.5% of 80% acetic acid,
2.5% 1 M HCl, pH 4.7) was added to each well overnight with incubation
at 37 C in 10% CO2. Cells were then pulled at the indicated times and the
absorbances were taken at 570 nm.
Inhibition of cdk2 growth curves.  293T cells were seeded at a density of
4   10
4 cells/plate (60 mm) and were transfected 24 h later with 5  g of
total DNA. Combinations of empty vector control and myc–Spy1 were
used with or without cdk2D145N. Furthermore, myc–Spy1- or control-
transfected cells were either treated with DMSO control or 7  M olomou-
cine (Sigma-Aldrich). Cells were trypsinized and triplicate plates were
counted every 24 h for each condition. The average values are represented
( SEM). Remaining cells at each time point were lysed, subjected to SDS-
PAGE, and analyzed for myc–Spy1 expression by immunoblotting.
Flow cytometry
293T cells were transfected as described above with 10  g of DNA. Cells
were trypsinized at the indicated times, washed twice in PBS, resuspended
at 2   10
6 cells in 1 ml of PBS, fixed by the addition of an equal amount of
ethanol, and frozen. Within 1 wk, fixed cells were pelleted, washed, and
resuspended in 300  l of PBS. Samples were then treated with 1  l of 10
mg/ml stock of DNase free RNase (Promega) and 50  l of 500 mg/ml pro-
pidium iodide (Boehringer) stock solution. Data were collected on a flow
cytometer within 6 h. The multicycle (M-cycle) program for cell cycle dis-
tribution histograms (Phoenix Flow Systems, Inc.) was used to analyze the
data.
siRNA
RNA interference assays were conducted through the construction of
siRNA for Spy1 (siSpy). The siSpy oligo (-GTACGAAATTTTTCCATGG-)
was synthesized, purified, and duplexed by Dharmacon Research. As a
negative control, a luciferase GL2 duplex siRNA was used (D-1000-Lu-5;
Dharmacon Research).
siRNA transfection. Subconfluent 293T cells (10
5 cells/ml) were seeded in
10-cm dishes. Cells were transfected using calcium phosphate precipitation
with 0.6 nM siSpy or siluc-GL2 duplex per plate. Cells were incubated at 3%
CO2 for 12 h and then returned to 10% CO2 after changing the media.
siRNA growth curves. Every 24 h, plates were pulled in triplicate and both
live and dead cells were counted by trypan blue exclusion. Surviving cells
were averaged at each time point and their SEM was determined. Remain-
ing cells were pooled for mRNA preparation as described above and sub-366 The Journal of Cell Biology | Volume 157, Number 3, 2002
jected to RT-PCR analysis for Spy1 mRNA production. The quantity and
quality of mRNA was determined through formaldehyde gel electrophoresis.
Mitotic index. 293T cells were plated on collagen-coated coverslips and
transfected with siSpy or siluc-GL2 control as described above. After the
media change, cells were grown for 48 h, stained with Hoechst stain
(0.7% NP-40, 4.7% formaldehyde, 11  g/ml Hoechst stain in PBS), and
analyzed by fluorescence microscopy.
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